Abbott Profits Rise As Covid-19 Diagnostic Sales Eclipse 400 Million Tests Demand for Abbott’s portfolio of tests for Covid-19 surged in the fourth quarter as the company delivered more than 300 million such diagnostics in the fourth quarter alone and 400 million since the pandemic began in early 2020.